New way to identify patients at risk of dysphagia after head and neck cancer treatment

	Tweet

At the 3rd International Conference on innovative approaches in Head and Neck Oncology (ICHNO), Dr Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7 study. The study, conducted across the country, investigated risk factors for developing dysphagia (swallowing dysfunction), after undergoing radiotherapy treatment for a head & neck cancer. “We followed 1,476 patients with squamous cell carcinoma of the head and neck and found out the existence of factors related to the cancer itself, to the patient and to the treatment influencing the development of dysphagia,” said Dr Mortensen.

Dysphagia may be acute (starting in direct association with treatment) or late (starting months to years after treatment). Risk factors for developing severe acute dysphagia were large tumours, spreading of cancer cells to the lymph nodes, swallowing problems at the time of diagnosis, 6 treatments per week and tumour location other than the vocal cords. Risk factors for developing late dysphagia were large tumours, swallowing problems at the time of diagnosis and tumour location other than the vocal cords.

83% of all head & neck cancer patients develop some kind of dysphagia, but this predictive model will have a major impact on patient quality of life.

"These results are very important,” said Dr JA Langendijk from the University Medical Center of Groningen, The Netherlands. “Today, with the increasing use of intensity modulated radiotherapy (IMRT), the dose to the salivary glands is reduced resulting in lower risks on xerostomia (dry mouth). However, swallowing dysfunction is remaining an important side effect following irradiation in the head and neck region. Therefore, the identification of patients that are at highest risk for dysphagia, in particular late and persistent, is of major importance as this will help us to provide them with preventive measures”, said Dr Langendijk.

Gastric tubes insertion and swallowing exercises could be prescribed and prevent Malnutrition and weight loss. “This study will be very helpful to improve the quality of life of patients,” noted Dr Mortensen. “Indeed, these measures at an early stage of the treatment will considerably reduce swallowing disorders”.

But the results will also lead to a better treatment. “Dysphagia is a limiting factor for further intensification of head and neck radiotherapy. This is why the knowledge provided here may help us to better tailor treatments for the patients: it may allow us to increase the intensity of the treatment while maintaining their quality of life,” concluded Dr Mortensen.

###

Contact: Cecile Hardon-Villard

European Society for Medical Oncology

RELATED STORIES:
New technique holds promise for rare eye cancer   Protein associated with growth of tumors may prevent the spread of cancer   Could smoking pot cut risk of head, neck cancer?   Convergence in head and neck cancer   Evidence “increasingly against” phone cancer risk   Dental X-rays May Raise Risk of Brain Cancer   Brain Cancer Experts and Resources at Johns Hopkins   Target for Therapeutic Drugs to Fight Most Common Adult Brain Cancer   Early morning smokers have increased risk of lung and head and neck cancers   UVA Brain Cancer Trials Lead to FDA Accelerated Approval of Medication   Minimizing side effects from chemoradiation could help brain cancer patients live longer   Tobacco and alcohol use independently increase risk of head and neck cancer   Sex virus blamed for rise in head and neck cancers   Study finds 231 new genes associated with head and neck cancer   Immune deficiency linked to a type of eye cancer   Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients After Neck Dissection   Disparities among patients with extremity soft-tissue sarcomas   Some brain tumors mimic the genetic program of germline cells   Sensitizing tumor response to cancer therapy   Most common adult brain cancer linked to gene deletion, Stanford doctors say   Certain head and neck cancer patients benefit from second round of treatment   Prenatal Vitamins May Reduce Risk of Brain Tumors in Children

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]